ConductScience.org, home

Trial · NCT07893756

Evaluation of Silver Diamine Fluoride, Sodium Fluoride With Casein Phosphopeptide-Amorphous Calcium Phosphate(MI Varnish) and Dycal to Arrest Caries When Used in Indirect Pulp Capping Procedures in Children

NCT07893756, Phase 2, Completed, University of Jazan

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Evaluation of Silver Diamine Fluoride, Sodium Fluoride With Casein Phosphopeptide-Amorphous Calcium Phosphate(MI Varnish) and Dycal to Arrest Caries When Used in Indirect Pulp Capping Procedures in Children. Trials, record NCT07893756. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07893756

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Evaluation of Silver Diamine Fluoride, Sodium Fluoride With Casein Phosphopeptide-Amorphous Calcium Phosphate(MI Varnish) and Dycal to Arrest Caries When Used in Indirect Pulp Capping Procedures in Children
NCT number
NCT07893756
Status
Completed
Phases
Phase 2
Enrollment
90 participants, actual
Lead sponsor
University of Jazan
Conditions
Early Childhood Caries (ECC), Color Stability of Restoration, Caries Arrested, Caries,Dental
Interventions
Silver Diamine Fluoride (SDF, 38%) gel, Sodium Fluoride with CPP-ACP (MI varnish), Calcium Hydroxide (CH)
First posted
2026-10-26
Last updated
2026-10-26

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryClinical assessment of pulpitis to determine success of indirect pulp capping procedureThe outcomes will be clinically assessed from the date of intervention up to 3 months for success of pulp capping procedure.
All teeth after intervention will be clinically assessed for success of pulp capping procedure. Clinical assessment of pulpitis was done based on following criteria * Tenderness to percussion or palpation * Tooth mobility * Signs of soft tissue inflammation, sinus tract, or fistula formation * Presence or absence of postoperative pain If the tooth is asymptomatic with no signs of pulpitis , then the tooth is recorded as treatment positive. If any tooth shows any above signs of pulpitis it will be evaluated as treatment negative.
PrimaryAssessment of color stability of restorations placed after indirect pulp capping procedureThe outcome will be assessed before intervention, immediately after placing the restoration up to 3 months using both Spectrophotometer and Smartphone- based digital system.
Color evaluation of the carious site was performed using both an intraoral spectrophotometer (VITA Easyshade® Advance) and a smartphone-based digital system (Chromatcher) using CIELAB( all perceptible colors using three values) scores . The change in visual perception was calculated with the Delta E (▲E) values for both Spectrophotometer and Smartphone- based digital system.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07893756

GET https://conductscience.org/api/trials/v1/NCT07893756/registered